We are live on ! Find out more
QTTB icon

Q32 Bio

86 hedge funds and large institutions have $588M invested in Q32 Bio in 2019 Q2 according to their latest regulatory filings, with 29 funds opening new positions, 40 increasing their positions, 10 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

383% more first-time investments, than exits

New positions opened: 29 | Existing positions closed: 6

300% more repeat investments, than reductions

Existing positions increased: 40 | Existing positions reduced: 10

30% more funds holding

Funds holding: 6686 (+20)

0.41% more ownership

Funds ownership: 3.42%3.83% (+0.41%)

8% less capital invested

Capital invested by funds: $640M → $588M (-$52.4M)

50% less funds holding in top 10

Funds holding in top 10: 42 (-2)

Holders
86
Holders Change
+20
Holders Change %
+30.3%
% of All Funds
1.87%
Holding in Top 10
2
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-50%
% of All Funds
0.04%
New
29
Increased
40
Reduced
10
Closed
6
Calls
Puts
Net Calls
Net Calls Change

QTTB Hedge Fund Activity: Q2 2019 in Review

86 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in Q32 Bio (QTTB) for Q2 2019, worth a combined $588M — down 8.2% from $640M a quarter earlier.

Buyers outnumbered sellers: 29 funds opened new QTTB positions and 6 closed out — a net gain of 23 holders — while 40 added to existing stakes and 10 trimmed.

The largest buyer was Bellevue Group, opening a new position worth an estimated $30.6M. The largest seller was Sphera Funds Management, exiting entirely with an estimated $4.46M sold.

  • 86 institutional investors held Q32 Bio (QTTB) as of Q2 2019, up from 66 in Q1 2019.
  • Funds reported $588M of Q32 Bio stock for Q2 2019, down 8.2% quarter-over-quarter.
  • 29 funds opened new Q32 Bio positions in Q2 2019 and 6 closed out, a net change of +23 holders.
  • The largest Q32 Bio buyer in Q2 2019 was Bellevue Group, an estimated $30.6M added.
  • The largest Q32 Bio seller in Q2 2019 was Sphera Funds Management, an estimated $4.46M sold.

Based on aggregated 13F filings for Q2 2019.